We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-10.56%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$273M
AUM Growth
+$47.4M
(+21%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
27.41%
Top 10 Holdings %
Top 10 Hldgs %
53.37%
Holding
60
New
18
Increased
13
Reduced
8
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$11.5M |
| 2 |
Cardinal Health
CAH
|
+$10.9M |
| 3 |
Eli Lilly
LLY
|
+$10.6M |
| 4 |
SHPG
Shire pic
SHPG
|
+$10.6M |
| 5 |
AGN
Allergan plc
AGN
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
+$25.9M |
| 2 |
Cigna
CI
|
+$7.15M |
| 3 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$6.51M |
| 4 |
Sanofi
SNY
|
+$6.32M |
| 5 |
AbbVie
ABBV
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.73% |
| 2 | Industrials | 1.65% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Teva Pharmaceuticals
TEVA
$41.2B
| – | – |
-42,610
| Closed | -$2.8M |
|
52
UnitedHealth
UNH
$383B
| – | – |
-35,500
| Closed | -$4.18M |
|
53
Zimmer Biomet
ZBH
$18.4B
| – | – |
-54,499
| Closed | -$5.43M |
|
|
NTUS
54
DELISTED
Natus Medical Inc
NTUS
| – | – |
-70,500
| Closed | -$3.39M |
|
|
PETX
55
DELISTED
Aratana Therapeutics, Inc.
PETX
| – | – |
-97,376
| Closed | -$543K |
|
|
AET
56
DELISTED
Aetna Inc
AET
| – | – |
-50,700
| Closed | -$5.48M |
|
|
STJ
57
DELISTED
St Jude Medical
STJ
| – | – |
-92,800
| Closed | -$5.73M |
|
|
RLYP
58
DELISTED
RELYPSA INC COM
RLYP
| – | – |
-10,000
| Closed | -$283K |
|
|
DYAX
59
DELISTED
DYAX CORPORATION
DYAX
| – | – |
-687,600
| Closed | -$25.9M |
|
|
CTIC
60
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| – | – |
-529,226
| Closed | -$6.51M |
|
Similar funds
GUB
KLI
JA
WIC
AAM
TCM
CA
SAM
Sio Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Sio Capital Management held 60 positions worth $273M, up 21% from $226M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Sio Capital Management deployed $74.9M of net new capital in Q1 2016, opening 18 new positions and adding to 13 existing holdings. Its largest new stake was Amgen: 77,721 shares worth $11.7M.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 78% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Sanofi, an estimated $6.32M trimmed.
- Sio Capital Management's largest Q1 2016 buy was Amgen: 77,721 shares worth $11.7M.
- Sio Capital Management added most to Quotient Limited Ordinary Shares in Q1 2016, an estimated $5.96M increase.
- Sio Capital Management's biggest Q1 2016 reduction was Sanofi, cutting an estimated $6.32M.
- Sio Capital Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $25.9M.
- Sio Capital Management's ten largest holdings make up 53% of its $273M portfolio in Q1 2016.
- Sio Capital Management opened 18 new positions and closed 18 in Q1 2016.
- Sio Capital Management's portfolio value rose 21% quarter-over-quarter to $273M.
Based on Sio Capital Management's 13F filing for Q1 2016, filed 16 May 2016.